and were directly connected to Mehta. The remaining 21 entities were restricted from accessing the securities market for a period of three years.
The irregularities were figured out by SEBI after it probed into the stock trading activities of 12 firms, since March 2009 to 15 December 2009. It its probe, SEBI identified huge changes in the prices of the shares. The 12 firms include Mavens Biotech, KSL & Industries, KBS Capital Management, Lotus Eye Care Hospitals, Panoramic Universal, Asian Star